Litcius/Paper detail

Inhibition of myeloid differentiation factor 2 attenuates cardiometabolic impairments via reducing cardiac mitochondrial dysfunction, inflammation, apoptosis and ferroptosis in prediabetic rats

Natticha Sumneang, Thura Tun Oo, Kodchanan Singhanat, Chayodom Maneechote, Busarin Arunsak, Wichwara Nawara, Wasana Pratchayasakul, Juthipong Benjanuwattra, Nattayaporn Apaijai, Guang Liang, Siriporn C. Chattipakorn, Nipon Chattipakorn

2021Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease20 citationsDOI

Topics & Concepts

MedicinePrediabetesInflammationCardiac function curveOxidative stressInternal medicineNecroptosisEndocrinologyProinflammatory cytokineMyeloidInsulin resistanceHeart failureApoptosisDiabetes mellitusProgrammed cell deathType 2 diabetesBiologyBiochemistryAdipokines, Inflammation, and Metabolic DiseasesImmune cells in cancerPeroxisome Proliferator-Activated Receptors
Inhibition of myeloid differentiation factor 2 attenuates cardiometabolic impairments via reducing cardiac mitochondrial dysfunction, inflammation, apoptosis and ferroptosis in prediabetic rats | Litcius